Patents by Inventor Elsa COMPTE

Elsa COMPTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000832
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Application
    Filed: September 14, 2023
    Publication date: January 4, 2024
    Inventors: Elsa COMPTE, Patrick MAUREL, Sophie GRIVES-JERPHAGNON, Cyril LAVAUD, Lorraine BENIGNO-ANTON, Jean-Claude MAUREL
  • Publication number: 20210315931
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Application
    Filed: July 5, 2019
    Publication date: October 14, 2021
    Inventors: Elsa COMPTE, Patrick MAUREL, Sophie GRIVES-JERPHAGNON, Cyril LAVAUD, Lorraine BENIGNO-ANTON, Jean-Claude MAUREL
  • Publication number: 20190192420
    Abstract: The present invention relates to reverse-micellar systems comprising at least an active agent, an acylglycerol, a sterol, lecithin, ethanol and water, for use in chelation and/or sequestering of a radionuclide and/or a metal in a patient. The invention also relates to the reverse-micellar systems and to pharmaceutical compositions comprising said reverse-micellar systems.
    Type: Application
    Filed: November 26, 2018
    Publication date: June 27, 2019
    Inventors: Caroline BAUER, Elsa COMPTE, Olivier GREMY, Laurent MICCOLI, Jaime Francisco ANGULO-MORA, Jean-Claude MAUREL
  • Publication number: 20180200295
    Abstract: The present invention relates to a method for in situ preparation of cyano-bridged coordination polymers as metal nanoparticles within a biocompatible reverse micellar system by mixing at least two reverse micellar systems, each one containing at least one metal salt precursor. The invention also relates to the stabilization of theses nanoparticles by using a biocompatible reverse micellar system. This system takes part of the synthesis as a nanoreactor which comprises at least an acylglycerol, a sterol, lecithin, ethanol and water for the preparation of stable cyano-bridged metal nanoparticles without any use of additional stabilizer agent.
    Type: Application
    Filed: July 8, 2016
    Publication date: July 19, 2018
    Inventors: Jean-Claude MAUREL, Elsa COMPTE, Cyril LAVAUD, Yannick GUARI, Joulia GUARI, Jérôme LONG
  • Publication number: 20170035909
    Abstract: The present invention relates to reverse-micellar systems comprising at least an active agent, an acylglycerol, a sterol, lecithin, ethanol and water, for use in chelation and/or sequestering of a radionuclide and/or a metal in a patient. The invention also relates to the reverse-micellar systems and to pharmaceutical compositions comprising said reverse-micellar systems.
    Type: Application
    Filed: February 17, 2015
    Publication date: February 9, 2017
    Inventors: Caroline BAUER, Elsa COMPTE, Olivier GREMY, Laurent MICCOLI, Jaime Francisco ANGULO-MORA, Jean-Claude MAUREL